About Anthony Manning
Anthony Manning is a board member at Cyrus Biotechnology.
Anthony Manning first appears on SEC filings in 2024.
Experience
This experience comes from Anthony Manning's profile and from SEC filings. For roles taken from filings, the years are when the filings name Anthony Manning in the role, so the role may have started earlier or lasted longer.
BI
BioCryst Pharmaceuticals, Inc. Current
Chairman of the Scientific Advisory Board
2026 – Present
MB
Metaphore Biotechnologies Current
Chairman of the Scientific Advisory Board
2026 – Present
Cyrus Biotechnology, Inc. Current
Board Member
Member Board of Directors (2024 – Present)
2024 – Present · Seattle, WA
Develops protein-based drug candidates for its own pipeline and biotechnology and pharmaceutical partners.
MT
Monte Rosa Therapeutics Current
Member Board of Directors
2023 – Present
PT
ProFound Therapeutics Current
Scientific Advisory Board Member
2022 – Present
4D
48Hour Discovery Current
Scientific Advisory Board Member
2022 – Present
ML
Manning Bio Worldwide LLC Current
Principal
2021 – Present
PT
Palatin Technologies
Member Board of Directors
2017 – 2025
BS
BioHybrid Solutions
Scientific Advisory Board Member
2022 – 2024
MP
Momenta Pharmaceuticals
Chief Scientific Officer
2013 – 2021
AT
Aileron Therapeutics
Senior Vice President, Research & Preclinical Development
2011 – 2012
BI
Biogen Idec
Vice President, Inflammation & Autoimmune Diseases Research
2007 – 2011
RP
Roche Pharmaceuticals
Vice President and Global Head, Inflammation, Autoimmunity & Transplantation Research
2002 – 2007
PC
Pharmacia Corp
Vice President, Arthritis & Pain Research (2000 – 2002)
Senior Research Scientist (1992 – 1996)
1992 – 2002
SI
Signal Pharmaceuticals Inc
Senior Director, Research & Preclinical Development
1996 – 2000
BM
Baylor College of Medicine
Assistant Professor
1990 – 1992
US
University of Otago Medical School
Masonic Postgraduate Clinical Fellow
1989 – 1990
Key Colleagues at Startups
The people Anthony Manning works with at each company, as listed on that company's latest Form D.
Cyrus Biotechnology, Inc. · Form D/A, May 8, 2026
CW
Chad Waite
Board Member
Yifan Song
Chief Technology Officer and director
JS
Jason Smith
Board Member
Mark Benjamin
President and EVP Business Development
Lucas Nivon
Chief Executive Officer and director
RS
Ramakrishna Satyavolu
Director